This is a preview of subscription content, log in via an institution to check access.
Reference
Youngerman BE, et al. Cost-effectiveness analysis of responsive neurostimulation for drug-resistant focal onset epilepsy. Epilepsia : 29 Aug 2021. Available from: URL: http://doi.org/10.1111/epi.17049
Rights and permissions
About this article
Cite this article
Responsive neurostimulation for drug-resistant focal onset epilepsy may be cost effective in the USA. PharmacoEcon Outcomes News 887, 22 (2021). https://doi.org/10.1007/s40274-021-08038-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08038-1